State Of New Jersey Common Pension Fund D Clovis Oncology, Inc. Transaction History

State Of New Jersey Common Pension Fund D

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 23, 2019	SELL	$3.93 - $15.35 $1.14 Million - $4.45 Million	-290,000 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$29.37 - $49.48 $587,400 - $989,599	20,000 Added 7.41%	290,000 $8.52 Million
Q2 2018 Jul 30, 2018	BUY	$42.06 - $62.4 $420,600 - $624,000	10,000 Added 3.85%	270,000 $12.3 Million
Q1 2018 May 08, 2018	BUY	$50.12 - $67.72 $11 Million - $14.9 Million	220,000 Added 550.0%	260,000 $13.7 Million
Q4 2017 Feb 06, 2018	BUY	$57.69 - $84.58 $1.44 Million - $2.11 Million	25,000 Added 166.67%	40,000 $2.72 Million
Q3 2017 Oct 25, 2017	BUY	$67.17 - $84.81 $1.01 Million - $1.27 Million	15,000	15,000 $1.24 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.